Annual Current Assets
$226.98 M
+$67.01 M+41.89%
December 31, 2024
Summary
- As of March 13, 2025, AVBP annual total current assets is $226.98 million, with the most recent change of +$67.01 million (+41.89%) on December 31, 2024.
- During the last 3 years, AVBP annual current assets has risen by +$184.03 million (+428.45%).
- AVBP annual current assets is now at all-time high.
Performance
AVBP Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$226.98 M
+$67.01 M+41.89%
December 31, 2024
Summary
- As of March 13, 2025, AVBP quarterly total current assets is $226.98 million, with the most recent change of +$67.01 million (+41.89%) on December 31, 2024.
- Over the past year, AVBP quarterly current assets has dropped by -$81.53 million (-26.43%).
- AVBP quarterly current assets is now -30.69% below its all-time high of $327.48 million, reached on March 31, 2024.
Performance
AVBP Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
AVBP Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.9% | -26.4% |
| 3 y3 years | +428.4% | -26.4% |
| 5 y5 years | +428.4% | -26.4% |
AVBP Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +428.4% | -30.7% | +41.9% |
| 5 y | 5-year | at high | +428.4% | -30.7% | +41.9% |
| alltime | all time | at high | +428.4% | -30.7% | +41.9% |
ArriVent BioPharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $47.96 M(+1432.4%) | $226.98 M(+41.9%) |
| Sep 2024 | - | $159.97 M(-48.1%) |
| Jun 2024 | - | $308.51 M(-5.8%) |
| Mar 2024 | - | $327.48 M(+104.7%) |
| Dec 2023 | $3.13 M | $159.97 M(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $179.98 M(-9.4%) |
| Jun 2023 | - | $198.69 M(+8.8%) |
| Dec 2022 | $211.00 K(+142.5%) | - |
| Dec 2022 | - | $182.62 M |
| Dec 2021 | $87.00 K | - |
FAQ
- What is ArriVent BioPharma annual total current assets?
- What is the all time high annual current assets for ArriVent BioPharma?
- What is ArriVent BioPharma annual current assets year-on-year change?
- What is ArriVent BioPharma quarterly total current assets?
- What is the all time high quarterly current assets for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly current assets year-on-year change?
What is ArriVent BioPharma annual total current assets?
The current annual current assets of AVBP is $226.98 M
What is the all time high annual current assets for ArriVent BioPharma?
ArriVent BioPharma all-time high annual total current assets is $226.98 M
What is ArriVent BioPharma annual current assets year-on-year change?
Over the past year, AVBP annual total current assets has changed by +$67.01 M (+41.89%)
What is ArriVent BioPharma quarterly total current assets?
The current quarterly current assets of AVBP is $226.98 M
What is the all time high quarterly current assets for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly total current assets is $327.48 M
What is ArriVent BioPharma quarterly current assets year-on-year change?
Over the past year, AVBP quarterly total current assets has changed by -$81.53 M (-26.43%)